Doxorubicin-eluting intra-arterial embolization
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Doxorubicin-eluting intra-arterial embolization, covering 2022-03-25 to 2022-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis [Phase 2]